Executives gathered at BMI on Monday evening for a public lecture and discussion on “Biogenetics & Biotechnology: The Human Body's Ability to Self-Heal”. The high-level “BMI Presents…” session was led by Adas Darinskas, who has worked for more than 17 years in international biomedical research and the commercialization of advanced therapies and medical products.
The biomedical doctor, who has authored a number of scientific publications, reviewed his work in Sweden, Israel and Russia regarding the use of stem cells in oncology, treatment of incurable diseases, regenerative medicine and more. He is a co-founder of the first private cord blood bank in the Baltics, the biotech company Froceth and the anti-aging R&D firm Innovita Research.
“The future of medicine will be very closely related to our genetics and our genome,” Darinskas said. “We can now sequence a person’s genome in about 4 weeks for about 1400 euros, and then IT analysis of the information can increasingly help identify specific traits and problems or diseases so we can manage them in a targeted way,” he explained.
Technologies are revolutionizing surgery, where the area of the body that needs to be cut is getting smaller and smaller, and where surgeons can even operate remotely. Viruses are already being used to deliver genes to the body, some organs can be 3D printed, and work is underway on nanorobots able to perform extremely precise medical functions and treatments. Some advances, as in the use of certain types of stem cells, also require dealing with relevant ethical issues, he noted.
BMI Director General Jaunius Pusvaškis stressed the relevance of topic of medical advances “not only for those working in medicine, but also for people in business, and really for each and every one of us as individuals who of course want to be healthier and live longer.”